S'abonner

Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study - 12/02/21

Doi : 10.1016/j.rmed.2020.106245 
Lee Gazourian a, , William B. Thedinger b, Shawn M. Regis c, Elizabeth J. Pagura a, Lori Lyn Price d, e, Melissa Gawlik f, Cristina F. Stefanescu g, Carla Lamb a, Kimberly M. Rieger-Christ h, Harpreet Singh i, Marcel Casasola i, Alexander R. Walker i, Arashdeep Rupal i, Avignat S. Patel a, Carolyn E. Come a, Ava M. Sanayei b, William P. Long b, Giulia S. Rizzo j, Andrea B. McKee c, George R. Washko k, l, Raul San Jose Estepar k, m, Christoph Wald n, Brady J. McKee n, Carey C. Thomson i, o, p, 1, Timothy N. Liesching a, 1
a Department of Medicine, Division of Pulmonary and Critical Care Medicine, Lahey Hospital & Medical Center, Burlington, MA, 01805, USA 
b Tufts University School of Medicine, Boston, MA, 02111, USA 
c Department of Radiation Oncology, Lahey Hospital & Medical Center, Burlington, MA, 01805, USA 
d Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 02111, USA 
e Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, 02111, USA 
f Quality and Safety, Lahey Hospital & Medical Center, Burlington, MA, 01805, USA 
g Department of Pediatrics, Tufts Medical CenterBoston, MA, 02111, USA 
h Translational Research, Lahey Hospital & Medical Center, Burlington, MA, 01805, USA 
i Department of Medicine, Mount Auburn Hospital, Cambridge, MA, 02138, USA 
j Department of General Surgery, UMass Memorial Medical Center, Worcester, MA, 01655, USA 
k Department of Medicine, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA 
l Applied Chest Imaging Laboratories, Brigham and Women's Hospital, Boston, MA, 02115, USA 
m Department of Radiology, Brigham and Women's Hospital Boston, MA, 02115, USA 
n Department of Radiology, Lahey Hospital & Medical Center, Burlington, MA, 01805, USA 
o Harvard Medical School, Boston, MA, 02115, USA 
p Division of Pulmonary and Critical Care Medicine, Mount Auburn Hospital, Cambridge, MA, 02138, USA 

Corresponding author.

Abstract

Background

In the United States, 9 to 10 million Americans are estimated to be eligible for computed tomographic lung cancer screening (CTLS). Those meeting criteria for CTLS are at high-risk for numerous cardio-pulmonary co-morbidities. The objective of this study was to determine the association between qualitative emphysema identified on screening CTs and risk for hospital admission.

Study design and Methods

We conducted a retrospective multicenter study from two CTLS cohorts: Lahey Hospital and Medical Center (LHMC) CTLS program, Burlington, MA and Mount Auburn Hospital (MAH) CTLS program, Cambridge, MA. CTLS exams were qualitatively scored by radiologists at time of screening for presence of emphysema. Multivariable Cox regression models were used to evaluate the association between CT qualitative emphysema and all-cause, COPD-related, and pneumonia-related hospital admission.

Results

We included 4673 participants from the LHMC cohort and 915 from the MAH cohort. 57% and 51.9% of the LHMC and MAH cohorts had presence of CT emphysema, respectively. In the LHMC cohort, the presence of emphysema was associated with all-cause hospital admission (HR 1.15, CI 1.07–1.23; p < 0.001) and COPD-related admission (HR 1.64; 95% CI 1.14–2.36; p = 0.007), but not with pneumonia-related admission (HR 1.52; 95% CI 1.27–1.83; p < 0.001). In the MAH cohort, the presence of emphysema was only associated with COPD-related admission (HR 2.05; 95% CI 1.07–3.95; p = 0.031).

Conclusion

Qualitative CT assessment of emphysema is associated with COPD-related hospital admission in a CTLS population. Identification of emphysema on CLTS exams may provide an opportunity for prevention and early intervention to reduce admission risk.

Le texte complet de cet article est disponible en PDF.

Highlights

Qualitative emphysema is associated with risk for COPD hospitalization.
Lung cancer screening represents are an opportunity to screen for COPD.
Lung cancer screening represents an opportunity to improve vaccination rates.
Lung cancer screening represents an opportunity to improve smoking cessation rates.

Le texte complet de cet article est disponible en PDF.

Keywords : Emphysema, Lung cancer, Lung cancer screening


Plan


© 2020  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 176

Article 106245- janvier 2021 Retour au numéro
Article précédent Article précédent
  • COPD in women – New results presented
  • By Helena Backman, Johann Christian Virchow, Bo Lundbäck
| Article suivant Article suivant
  • A few more steps lead to improvements in endothelial function in severe and very severe COPD
  • Dario Kohlbrenner, Christian F. Clarenbach, Sira Thiel, Maurice Roeder, Malcolm Kohler, Noriane A. Sievi

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.